COVID-19 Clinical Trial
Official title:
National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19
Cross-sectional study based on a French national survey aimed to described and identify the most frequent symptoms of COVID-19 older patients.
This cross-sectional survey was initiated and conducted by the French Society of Geriatrics
and Gerontology. A standardized questionnaire was emailed to 1600 geriatrician members of the
French Society of Geriatrics and Gerontology throughout France between March 22, 2020 and
April 5, 2020. Geriatricians were asked to complete the survey for their last 10 patients
infected by the SARS-CoV-2. The study was declared to the Commission Nationale de
l'Informatique et des Libertés (CNIL) under the number ar20-0031v1.
For each patient, demographic characteristics (age, gender, residence place, care place,
autonomy according to the Groupe Iso Ressource (GIR)), medical history (presence of major
neurocognitive disorder, hypertension, diabetes, asthma or chronic obstructive pulmonary
disease (COPD), heart pathology, severe renal failure with a clearance of creatinine under
30ml/min, solid or liquid cancer) were collected. The symptoms within de 72 hours of the
actual disease were also collected for each patient including geriatric syndromes (fall,
hypoactive or hyperactive delirium, altered general status, altered conscience), general
symptoms (temperature, blood pressure), respiratory symptoms (cough, polypnea), ear nose and
throat (ENT) symptoms (rhinorrhea, odynophagia, otalgia, conjunctivitis, ageusia or
dysgeusia, anosmia), digestive symptoms (diarrhea, nausea or vomiting), and blood formula
modification (leucopenia (with count if available), lymphopenia (with count if available),
thrombopenia (with count if available).
Procedure Data were collected by the physician who was in charge of the patient between March
22, 2020 and April 5, 2020.
Given the main objective of the study was only descriptive, no calculation was required
concerning the number of subjects to include in the study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
| Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
| Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
| Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
| Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
| Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
| Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
| Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
| Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
| Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
| Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
| Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
| Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
| Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
| Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|